Latest Cutaneous leishmaniasis Stories
LEIDEN, The Netherlands, August 17 /PRNewswire/ -- A new consortium has been formed to boost drug development for the treatment of two deadly diseases, African sleeping sickness and Leishmaniasis, which affect millions of people worldwide. A total budget of nearly 3.6 million euros has been allocated over the next 4 years, to develop effective drugs for these diseases. The consortium includes IOTA Pharmaceuticals, Mercachem, Nycomed, the Drugs for Neglected Diseases initiative, the...
SAN ANTONIO, March 5 /PRNewswire/ -- A plentiful, inexpensive, topical compound is as effective at treating the skin lesions of Middle Eastern and African leishmaniasis as is the standard therapy, a less-available, costlier compound injected into lesions. That's one of the findings of a research team from Johns Hopkins University, Harvard University, Thomas Jefferson University and led by Reza F. Ghohestani, M.D., Ph.D., director of the Texas Institute of Dermatology and an associate...
SEATTLE, Jan. 22 /PRNewswire/ -- IDRI (Infectious Disease Research Institute) announced it has granted the Instituto Butantan, a Brazilian biomedical research institution, an exclusive license in Latin America and a non-exclusive license in the rest of the world to use two of IDRI's lead vaccine antigen candidates for the prevention and treatment of leishmaniasis in humans and dogs. IDRI will provide technical assistance to the Instituto Butantan for the development and evaluation of...
Hundreds of millions of people, mainly in developing countries, are disabled by infectious diseases, according to the World Health Organization.More than 12 million people in 88 countries are infected with leishmaniasis, a parasitic disease spread by the bite of infected sand flies. Nearly 2 million new cases are reported and about 70,000 people die from the disease annually.Researchers at the University of Illinois at Chicago have discovered that compounds derived from a natural product can...
By Derkach, Yelena Brown, Clarence William Jr The "Clinical Snapshot" series provides a concise examination of a clinical presentation including history, treatment, patient education, and nursing measures. Using the format here, you are invited to submit your "Clinical Snapshot" to Dermatology Nursing. History A 31-year-old Hispanic male referred to the dermatology clinic presented with painful, bleeding, and pruritic ulcers on his left chin and left medial knee for 6 months. Two months...
By Thakur, C P Paromomycin, an aminoglycoside, is known to cause several side effects like nephrotoxicity and ototoxicity like other aminoglycosides but tetany has not been reported. Three cases of tetany were detected in the patients of kala-azar treated with paromomycin. They were promptly treated with intravenous 10 per cent calcium gluconate and tetany was relieved immediately and treatment with paromomycin continued with oral calcium supplement. After completion of 21 days treatment...
By Sherry Jacobson, The Dallas Morning News Dermatologists in North Texas were alerted Friday to be on the lookout for a rare skin infection caused by a parasite that may have migrated north from the Mexican border. The disease, leishmaniasis, typically causes a half-dollar-sized boil that takes six to 12 months to heal. It is not considered life-threatening. Doctors at UT Southwestern Medical Center said they have identified nine cases of the skin disease in North Texans in recent months....
